N-(3-methyl-5-nitrobenzyl)cyclopropanamine, 98%, 500mg

4,4,5,5-Tetramethyl-2-(3-((4-nitrobenzyl)oxy)phenyl)-1,3,2-dioxaborolane, 100mg

6-chloro-2-methyl-3,4-dihydropyrimidin-4-one, 95%, 5g

Cbz-L-2,4-Diaminobutyric acid, 95.0%, 5g

6-Bromo-4-chloropyrido[2,3-d]pyrimidine, 95.0%, 5g

TERT-BUTYL (4,5-DIBROMOTHIOPHEN-2-YL)CARBAMATE, 95.0%, 100mg

Fmoc-Thr(tBu)-OH, 97%, 100g

2-Benzyloxynicotinic acid, 97%, 5g

1-Phenyl-4,5-dihydro-1H-pyrazol-3-ylamine, 95.0%, 1g

2-(Chloromethyl)oxazolo[4,5-b]pyridine, 95.0%, 1g

tert-butyl 3-(3-bromophenyl)piperazine-1-carboxylate, 95.0%, 1g

Oxyde d'antimoine(III), min 99 %, pa, 100 g, emballage plastique.

Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propen-1-yl]-, hydrochloride (1:2), 99%, 25g